PURPOSE: To describe frequency, clinical characteristics, and visual prognosis of tubercular uveitis (TBU) in a nonendemic country. METHODS: We retrospectively reviewed 3743 charts of patients with endogenous uveitis visited from 2008 to 2018 at a tertiary referral centre in Rome, Italy. We included immunocompetent patients with diagnosis of TBU. Patients were divided in two groups: patients with history of uveitis without a previous diagnosis of TBU (group A) and patients at their first episode of TB uveitis (group B). RESULTS: TBU was diagnosed in 28 (0.75%) out of 3743 patients. Twelve (42.9%) patients came from tuberculosis endemic areas. All patients received specific antitubercular treatment (ATT) and were evaluated for a mean follow-up of 3.2 ± 2.9 years. Group A showed a greater number of ocular complications when compared with group B. ATT was effective in reducing the frequency of recurrences of uveitis in patients of group B. CONCLUSION: Intraocular inflammation can be the first manifestation of tuberculosis. Our data highlight that early diagnosis and specific treatment of TBU may allow to decrease recurrences and to improve visual outcomes.

Clinical and Epidemiological Study on Tubercular Uveitis in a Tertiary Eye Care Centre in Italy / La Cava, M; Bruscolini, A; Sacchetti, M; Pirraglia, M P; Moramarco, A; Marenco, M; Iaiani, G; Covelli, G; Rizzo, T; Abicca, I; Lambiase, A. - In: JOURNAL OF OPHTHALMOLOGY. - ISSN 2090-004X. - 2020:(2020). [10.1155/2020/4701820]

Clinical and Epidemiological Study on Tubercular Uveitis in a Tertiary Eye Care Centre in Italy

La Cava, M
Primo
Methodology
;
Bruscolini, A
Secondo
Investigation
;
Sacchetti, M
Supervision
;
Moramarco, A
Investigation
;
Marenco, M
Writing – Original Draft Preparation
;
Covelli, G
Investigation
;
Abicca, I
Penultimo
Investigation
;
Lambiase, A
Ultimo
Writing – Review & Editing
2020

Abstract

PURPOSE: To describe frequency, clinical characteristics, and visual prognosis of tubercular uveitis (TBU) in a nonendemic country. METHODS: We retrospectively reviewed 3743 charts of patients with endogenous uveitis visited from 2008 to 2018 at a tertiary referral centre in Rome, Italy. We included immunocompetent patients with diagnosis of TBU. Patients were divided in two groups: patients with history of uveitis without a previous diagnosis of TBU (group A) and patients at their first episode of TB uveitis (group B). RESULTS: TBU was diagnosed in 28 (0.75%) out of 3743 patients. Twelve (42.9%) patients came from tuberculosis endemic areas. All patients received specific antitubercular treatment (ATT) and were evaluated for a mean follow-up of 3.2 ± 2.9 years. Group A showed a greater number of ocular complications when compared with group B. ATT was effective in reducing the frequency of recurrences of uveitis in patients of group B. CONCLUSION: Intraocular inflammation can be the first manifestation of tuberculosis. Our data highlight that early diagnosis and specific treatment of TBU may allow to decrease recurrences and to improve visual outcomes.
2020
uveitis, tubercolosis, epidemiology
01 Pubblicazione su rivista::01a Articolo in rivista
Clinical and Epidemiological Study on Tubercular Uveitis in a Tertiary Eye Care Centre in Italy / La Cava, M; Bruscolini, A; Sacchetti, M; Pirraglia, M P; Moramarco, A; Marenco, M; Iaiani, G; Covelli, G; Rizzo, T; Abicca, I; Lambiase, A. - In: JOURNAL OF OPHTHALMOLOGY. - ISSN 2090-004X. - 2020:(2020). [10.1155/2020/4701820]
File allegati a questo prodotto
File Dimensione Formato  
La-Cava_Clinical_2020.pdf

accesso aperto

Note: https://www.hindawi.com/journals/joph/2020/4701820/
Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 2.14 MB
Formato Adobe PDF
2.14 MB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1385758
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 3
social impact